🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07333872
Active, not recruiting Not applicable

Evaluation of Pulpotomy, Partial Pulpotomy, and Direct Pulp Capping Using Mineral Trioxide Aggregate.

NCT07333872 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-06-01
Last updated
2026-01-13

Condition(s) studied

Vital Pulp Therapy in Primary Teeth

Investigational drug(s) / intervention(s)

pulp capping with MTA

pulp capping with MTA: Capping of the pulp tissue with a biocompatible material (MTA)

Study summary

A comparative evaluation for three vital pulp therapy techniques in primary molars using the same material (MTA)

Eligibility

Sex
ALL
Min age
4 Years
Max age
7 Years
Healthy volunteers
No
Inclusion Criteria: * articipants were cooperative children (4-7 years) with no systemic diseases or relevant allergies. Eligible teeth were restorable primary second molars with deep carious lesions and a diagnosis of reversible pulpitis, Exclusion Criteria: * spontaneous pain, edema, fistula, pathological mobility, or percussion sensitivity.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Delta university for science and technology Gamasa Dakahlia Governorate

More Delta University for Science and Technology trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07333872 on ClinicalTrials.gov ↗ ← All trials in Egypt